Human Herpersvirus 5 (HHV-5) Drug Market Report

Global and Region Human Herpersvirus 5 (HHV-5) Drug Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Jul 30, 2022
  • PAGES：137
  • REPORT CODE：GMM908801
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Human Herpersvirus 5 (HHV-5) Drug market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Human Herpersvirus 5 (HHV-5) Drugmarket, defines the market attractiveness level of Human Herpersvirus 5 (HHV-5) Drug market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Human Herpersvirus 5 (HHV-5) Drug industry, describes the types of Human Herpersvirus 5 (HHV-5) Drug market, the applications of major players and the market size, and deeply analyzes the current situation of the global Human Herpersvirus 5 (HHV-5) Drug market and the development prospects and opportunities of Human Herpersvirus 5 (HHV-5) Drug industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Human Herpersvirus 5 (HHV-5) Drug market in Chapter 13.

    By Player:

    • Haikou Kellett

    • Shandong Luo Xin Pharmaceutical

    • Chongqing Fu'an Pharmaceutical

    • Qianjiang Pharmaceuticals

    • Sichuan Cologne Pharmaceutical

    • Roche

    • Chongqing Winbond (acquisition of Sichuan Mingxin)

    • Upright and clear

    • GlaxoSmithKline

    • Livzon Pharmaceuticals

    • On the drug new Asia

    • Hubei Branch benefits medicine

    • Wuhan Hualong

    • Yangtze River Pharmaceutical

    By Type:

    • Ganciclovir

    • Valerian Gilivir Drugs

    • Acyclovir Drugs

    • Valacyclovir Drugs

    • Foscarnet Sodium Drugs

    By End-User:

    • Immunodeficiency Crowd

    • Organ Transplant Crowd

    • CMV Herpes Crowd

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Human Herpersvirus 5 (HHV-5) Drug Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Human Herpersvirus 5 (HHV-5) Drug Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Human Herpersvirus 5 (HHV-5) Drug Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Human Herpersvirus 5 (HHV-5) Drug Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Human Herpersvirus 5 (HHV-5) Drug Market Analysis and Outlook to 2022

    • 7.1 Global Human Herpersvirus 5 (HHV-5) Drug Consumption (2017-2022)

    • 7.2 United States Human Herpersvirus 5 (HHV-5) Drug Consumption (2017-2022)

    • 7.3 Europe Human Herpersvirus 5 (HHV-5) Drug Consumption (2017-2022)

    • 7.4 China Human Herpersvirus 5 (HHV-5) Drug Consumption (2017-2022)

    • 7.5 Japan Human Herpersvirus 5 (HHV-5) Drug Consumption (2017-2022)

    • 7.6 India Human Herpersvirus 5 (HHV-5) Drug Consumption (2017-2022)

    • 7.7 South Korea Human Herpersvirus 5 (HHV-5) Drug Consumption (2017-2022)

    8 Region and Country-wise Human Herpersvirus 5 (HHV-5) Drug Market Analysis and Outlook to 2028

    • 8.1 Global Human Herpersvirus 5 (HHV-5) Drug Consumption Forecast (2022-2028)

    • 8.2 United States Human Herpersvirus 5 (HHV-5) Drug Consumption Forecast (2022-2028)

    • 8.3 Europe Human Herpersvirus 5 (HHV-5) Drug Consumption Forecast (2022-2028)

    • 8.4 China Human Herpersvirus 5 (HHV-5) Drug Consumption Forecast (2022-2028)

    • 8.5 Japan Human Herpersvirus 5 (HHV-5) Drug Consumption Forecast (2022-2028)

    • 8.6 India Human Herpersvirus 5 (HHV-5) Drug Consumption Forecast (2022-2028)

    • 8.7 South Korea Human Herpersvirus 5 (HHV-5) Drug Consumption Forecast (2022-2028)

    9 Global Human Herpersvirus 5 (HHV-5) Drug Market Outlook by Types and Applications to 2022

    • 9.1 Global Human Herpersvirus 5 (HHV-5) Drug Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Ganciclovir Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Valerian Gilivir Drugs Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Acyclovir Drugs Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Valacyclovir Drugs Consumption and Growth Rate (2017-2022)

      • 9.1.5 Global Foscarnet Sodium Drugs Consumption and Growth Rate (2017-2022)

    • 9.2 Global Human Herpersvirus 5 (HHV-5) Drug Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Immunodeficiency Crowd Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Organ Transplant Crowd Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global CMV Herpes Crowd Consumption and Growth Rate (2017-2022)

    10 Global Human Herpersvirus 5 (HHV-5) Drug Market Outlook by Types and Applications to 2028

    • 10.1 Global Human Herpersvirus 5 (HHV-5) Drug Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Ganciclovir Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Valerian Gilivir Drugs Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Acyclovir Drugs Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.4 Global Valacyclovir Drugs Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.5 Global Foscarnet Sodium Drugs Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Human Herpersvirus 5 (HHV-5) Drug Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Immunodeficiency Crowd Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Organ Transplant Crowd Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global CMV Herpes Crowd Consumption Forecast and Growth Rate (2022-2028)

    11 Global Human Herpersvirus 5 (HHV-5) Drug Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Human Herpersvirus 5 (HHV-5) Drug Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Human Herpersvirus 5 (HHV-5) Drug Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Human Herpersvirus 5 (HHV-5) Drug Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Human Herpersvirus 5 (HHV-5) Drug Market Competitive Analysis

    • 14.1 Haikou Kellett

      • 14.1.1 Haikou Kellett Company Details

      • 14.1.2 Haikou Kellett Human Herpersvirus 5 (HHV-5) Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Haikou Kellett Human Herpersvirus 5 (HHV-5) Drug Product and Service

    • 14.2 Shandong Luo Xin Pharmaceutical

      • 14.2.1 Shandong Luo Xin Pharmaceutical Company Details

      • 14.2.2 Shandong Luo Xin Pharmaceutical Human Herpersvirus 5 (HHV-5) Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Shandong Luo Xin Pharmaceutical Human Herpersvirus 5 (HHV-5) Drug Product and Service

    • 14.3 Chongqing Fu'an Pharmaceutical

      • 14.3.1 Chongqing Fu'an Pharmaceutical Company Details

      • 14.3.2 Chongqing Fu'an Pharmaceutical Human Herpersvirus 5 (HHV-5) Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Chongqing Fu'an Pharmaceutical Human Herpersvirus 5 (HHV-5) Drug Product and Service

    • 14.4 Qianjiang Pharmaceuticals

      • 14.4.1 Qianjiang Pharmaceuticals Company Details

      • 14.4.2 Qianjiang Pharmaceuticals Human Herpersvirus 5 (HHV-5) Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Qianjiang Pharmaceuticals Human Herpersvirus 5 (HHV-5) Drug Product and Service

    • 14.5 Sichuan Cologne Pharmaceutical

      • 14.5.1 Sichuan Cologne Pharmaceutical Company Details

      • 14.5.2 Sichuan Cologne Pharmaceutical Human Herpersvirus 5 (HHV-5) Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Sichuan Cologne Pharmaceutical Human Herpersvirus 5 (HHV-5) Drug Product and Service

    • 14.6 Roche

      • 14.6.1 Roche Company Details

      • 14.6.2 Roche Human Herpersvirus 5 (HHV-5) Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Roche Human Herpersvirus 5 (HHV-5) Drug Product and Service

    • 14.7 Chongqing Winbond (acquisition of Sichuan Mingxin)

      • 14.7.1 Chongqing Winbond (acquisition of Sichuan Mingxin) Company Details

      • 14.7.2 Chongqing Winbond (acquisition of Sichuan Mingxin) Human Herpersvirus 5 (HHV-5) Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Chongqing Winbond (acquisition of Sichuan Mingxin) Human Herpersvirus 5 (HHV-5) Drug Product and Service

    • 14.8 Upright and clear

      • 14.8.1 Upright and clear Company Details

      • 14.8.2 Upright and clear Human Herpersvirus 5 (HHV-5) Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Upright and clear Human Herpersvirus 5 (HHV-5) Drug Product and Service

    • 14.9 GlaxoSmithKline

      • 14.9.1 GlaxoSmithKline Company Details

      • 14.9.2 GlaxoSmithKline Human Herpersvirus 5 (HHV-5) Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 GlaxoSmithKline Human Herpersvirus 5 (HHV-5) Drug Product and Service

    • 14.10 Livzon Pharmaceuticals

      • 14.10.1 Livzon Pharmaceuticals Company Details

      • 14.10.2 Livzon Pharmaceuticals Human Herpersvirus 5 (HHV-5) Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 Livzon Pharmaceuticals Human Herpersvirus 5 (HHV-5) Drug Product and Service

    • 14.11 On the drug new Asia

      • 14.11.1 On the drug new Asia Company Details

      • 14.11.2 On the drug new Asia Human Herpersvirus 5 (HHV-5) Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.11.3 On the drug new Asia Human Herpersvirus 5 (HHV-5) Drug Product and Service

    • 14.12 Hubei Branch benefits medicine

      • 14.12.1 Hubei Branch benefits medicine Company Details

      • 14.12.2 Hubei Branch benefits medicine Human Herpersvirus 5 (HHV-5) Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.12.3 Hubei Branch benefits medicine Human Herpersvirus 5 (HHV-5) Drug Product and Service

    • 14.13 Wuhan Hualong

      • 14.13.1 Wuhan Hualong Company Details

      • 14.13.2 Wuhan Hualong Human Herpersvirus 5 (HHV-5) Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.13.3 Wuhan Hualong Human Herpersvirus 5 (HHV-5) Drug Product and Service

    • 14.14 Yangtze River Pharmaceutical

      • 14.14.1 Yangtze River Pharmaceutical Company Details

      • 14.14.2 Yangtze River Pharmaceutical Human Herpersvirus 5 (HHV-5) Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.14.3 Yangtze River Pharmaceutical Human Herpersvirus 5 (HHV-5) Drug Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Human Herpersvirus 5 (HHV-5) Drug

    • Figure Human Herpersvirus 5 (HHV-5) Drug Picture

    • Table Global Human Herpersvirus 5 (HHV-5) Drug Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Human Herpersvirus 5 (HHV-5) Drug Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Human Herpersvirus 5 (HHV-5) Drug Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Human Herpersvirus 5 (HHV-5) Drug Consumption by Country (2017-2022)

    • Figure United States Human Herpersvirus 5 (HHV-5) Drug Consumption and Growth Rate (2017-2022)

    • Table Europe Human Herpersvirus 5 (HHV-5) Drug Consumption and Growth Rate (2017-2022)

    • Figure China Human Herpersvirus 5 (HHV-5) Drug Consumption and Growth Rate (2017-2022)

    • Figure Japan Human Herpersvirus 5 (HHV-5) Drug Consumption and Growth Rate (2017-2022)

    • Figure India Human Herpersvirus 5 (HHV-5) Drug Consumption and Growth Rate (2017-2022)

    • Figure South Korea Human Herpersvirus 5 (HHV-5) Drug Consumption and Growth Rate (2017-2022)

    • Figure Global Human Herpersvirus 5 (HHV-5) Drug Consumption Forecast by Country (2022-2028)

    • Figure United States Human Herpersvirus 5 (HHV-5) Drug Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Human Herpersvirus 5 (HHV-5) Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Human Herpersvirus 5 (HHV-5) Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Human Herpersvirus 5 (HHV-5) Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Human Herpersvirus 5 (HHV-5) Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Human Herpersvirus 5 (HHV-5) Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Ganciclovir Consumption and Growth Rate (2017-2022)

    • Figure Global Valerian Gilivir Drugs Consumption and Growth Rate (2017-2022)

    • Figure Global Acyclovir Drugs Consumption and Growth Rate (2017-2022)

    • Figure Global Valacyclovir Drugs Consumption and Growth Rate (2017-2022)

    • Figure Global Foscarnet Sodium Drugs Consumption and Growth Rate (2017-2022)

    • Figure Global Immunodeficiency Crowd Consumption and Growth Rate (2017-2022)

    • Figure Global Organ Transplant Crowd Consumption and Growth Rate (2017-2022)

    • Figure Global CMV Herpes Crowd Consumption and Growth Rate (2017-2022)

    • Figure Global Ganciclovir Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Valerian Gilivir Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Acyclovir Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Valacyclovir Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Foscarnet Sodium Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Immunodeficiency Crowd Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Organ Transplant Crowd Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global CMV Herpes Crowd Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Human Herpersvirus 5 (HHV-5) Drug Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Human Herpersvirus 5 (HHV-5) Drug Export by Region (Top 5 Countries) (2017-2028)

    • Table Haikou Kellett (Foundation Year, Company Profile and etc.)

    • Table Haikou Kellett Human Herpersvirus 5 (HHV-5) Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Haikou Kellett Human Herpersvirus 5 (HHV-5) Drug Product and Service

    • Table Shandong Luo Xin Pharmaceutical (Foundation Year, Company Profile and etc.)

    • Table Shandong Luo Xin Pharmaceutical Human Herpersvirus 5 (HHV-5) Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Shandong Luo Xin Pharmaceutical Human Herpersvirus 5 (HHV-5) Drug Product and Service

    • Table Chongqing Fu'an Pharmaceutical (Foundation Year, Company Profile and etc.)

    • Table Chongqing Fu'an Pharmaceutical Human Herpersvirus 5 (HHV-5) Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Chongqing Fu'an Pharmaceutical Human Herpersvirus 5 (HHV-5) Drug Product and Service

    • Table Qianjiang Pharmaceuticals (Foundation Year, Company Profile and etc.)

    • Table Qianjiang Pharmaceuticals Human Herpersvirus 5 (HHV-5) Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Qianjiang Pharmaceuticals Human Herpersvirus 5 (HHV-5) Drug Product and Service

    • Table Sichuan Cologne Pharmaceutical (Foundation Year, Company Profile and etc.)

    • Table Sichuan Cologne Pharmaceutical Human Herpersvirus 5 (HHV-5) Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sichuan Cologne Pharmaceutical Human Herpersvirus 5 (HHV-5) Drug Product and Service

    • Table Roche (Foundation Year, Company Profile and etc.)

    • Table Roche Human Herpersvirus 5 (HHV-5) Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Roche Human Herpersvirus 5 (HHV-5) Drug Product and Service

    • Table Chongqing Winbond (acquisition of Sichuan Mingxin) (Foundation Year, Company Profile and etc.)

    • Table Chongqing Winbond (acquisition of Sichuan Mingxin) Human Herpersvirus 5 (HHV-5) Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Chongqing Winbond (acquisition of Sichuan Mingxin) Human Herpersvirus 5 (HHV-5) Drug Product and Service

    • Table Upright and clear (Foundation Year, Company Profile and etc.)

    • Table Upright and clear Human Herpersvirus 5 (HHV-5) Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Upright and clear Human Herpersvirus 5 (HHV-5) Drug Product and Service

    • Table GlaxoSmithKline (Foundation Year, Company Profile and etc.)

    • Table GlaxoSmithKline Human Herpersvirus 5 (HHV-5) Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table GlaxoSmithKline Human Herpersvirus 5 (HHV-5) Drug Product and Service

    • Table Livzon Pharmaceuticals (Foundation Year, Company Profile and etc.)

    • Table Livzon Pharmaceuticals Human Herpersvirus 5 (HHV-5) Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Livzon Pharmaceuticals Human Herpersvirus 5 (HHV-5) Drug Product and Service

    • Table On the drug new Asia (Foundation Year, Company Profile and etc.)

    • Table On the drug new Asia Human Herpersvirus 5 (HHV-5) Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table On the drug new Asia Human Herpersvirus 5 (HHV-5) Drug Product and Service

    • Table Hubei Branch benefits medicine (Foundation Year, Company Profile and etc.)

    • Table Hubei Branch benefits medicine Human Herpersvirus 5 (HHV-5) Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Hubei Branch benefits medicine Human Herpersvirus 5 (HHV-5) Drug Product and Service

    • Table Wuhan Hualong (Foundation Year, Company Profile and etc.)

    • Table Wuhan Hualong Human Herpersvirus 5 (HHV-5) Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Wuhan Hualong Human Herpersvirus 5 (HHV-5) Drug Product and Service

    • Table Yangtze River Pharmaceutical (Foundation Year, Company Profile and etc.)

    • Table Yangtze River Pharmaceutical Human Herpersvirus 5 (HHV-5) Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Yangtze River Pharmaceutical Human Herpersvirus 5 (HHV-5) Drug Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US